Agile GxP Technologies
agilegxp.tech
Actively hiring
Health Care
Biologics & Biosimilars
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$175k
2 rounds on record
Latest round
$175k
Convertible Note · Aug 2022 · 4 yr ago
The money's age
Long since its last round
49 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 4, 2024
Took on debt financing $825k · SEC Form D
Aug 31, 2022
Raised a round Convertible Note $175k · SEC Form D
2022
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Debt Financing | Jun 2024 | $825k | — | SEC Form D |
| Convertible Note | Aug 2022 | $175k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Agile GxP Technologies, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
John SpohnExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
backs Halozyme
backs Cellestial Health logo
Similar startupsby what they do, their industry and backers
Retension Pharmaceuticals is a clinical-stage biopharmaceutical company developing RTN-001 and next-generation therapies for uncontrolled…
Stelexis BioSciences is a clinical-stage biopharmaceutical company created to accelerate novel treatments that aim to eradicate…
Together, we are reinventing the patient experience. Elektrofi is now part of Halozyme. Read more here .. By reengineering how medicines…
We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing…
ProtaGene is a world-leading CRO partner for the biopharmaceutical and gene and cell therapy industries.
Overview
Agile GxP Technologies want to accelerate the delivery of new therapies to patients by providing transformative technology to cGxP facilities for fast and compliant process changes or capacity expansions. Achieve biopharmaceutical process agility in your new or existing plant with Agile.
People
John Spohn
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Providence
United States
HQ